Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B Current Cash

The latest current cash for BDXB is $710M as of June 2026. That compares with $740M in the prior-year period — down 3.7% year over year. Investors often review this figure alongside Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDXB's current cash moved from $740M to $710M — a 3.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's operating scale or balance-sheet position.

A current cash figure of $710M for BDXB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BDXB's current cash ($710M), review year-over-year change from $740M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.